View in EDS HTML Full Text PDF Full Text

Mood Symptoms are Associated With Cognitive Status, Brain Amyloid‐Beta Deposition, and Plasma Biomarkers.

Saved in:
Bibliographic Details
Title: Mood Symptoms are Associated With Cognitive Status, Brain Amyloid‐Beta Deposition, and Plasma Biomarkers.
Authors: Wang, Jingru (AUTHOR), Huang, Lin (AUTHOR), Sun, Linfang (AUTHOR), Guo, Qihao (AUTHOR), He, Yingzi (AUTHOR), Jing, Yanping (AUTHOR), Ilardi, Ciro Rosario (AUTHOR)
Source: Depression & Anxiety (1091-4269). 11/14/2025, Vol. 2025, p1-9. 9p.
Subjects: Alzheimer's disease, Biomarkers, Anxiety, Amyloid plaque, Mental depression, Blood serum analysis, Affective disorders, Cognitive ability
Abstract: Background: Previous studies have indicated an association between mood symptoms and cognitive decline in the Alzheimer's disease (AD) spectrum. Amyloid‐beta (Aβ) deposition in the brain, which is a core pathological characteristic of AD, along with the presence of plasma biomarkers, such as phosphorylated tau protein (p‐tau), constitutes an early predictive indicator for AD. We attempted to explore the relationship between mood symptoms and the presence of AD‐related plasma biomarkers in patients with brain Aβ deposition. Method: We included 2612 participants aged ≥50 years (707 males; average age 66.98 ± 7.75 years) in this study. We used the Hamilton depression rating scale (HAMD) and Hamilton anxiety rating scale (HAMA) to assess mood symptoms. Cognitive status was categorized into AD, mild cognitive impairment (MCI), subjective cognitive decline (SCD), and normal cognition (NC). We used analysis of covariance (ANCOVA) to compare mood symptoms assessment scores in different cognitive groups after making adjustments for age, gender, and education. Linear regression analysis was used to investigate the association between mood scores and plasma biomarker levels, adjusting for positivity in Aβ PET imaging. Results: Compared to NC patients, patients with AD exhibited higher levels of depression (mean of 4.72 versus 3.39, p < 0.05), whereas patients with SCD exhibited higher levels of anxiety (mean of 6.28 versus 4.26, p < 0.05). After accounting for brain Aβ deposition and presence of plasma biomarkers, the plasma neurofilament light chain (NFL) levels (B = 0.211, SE = 0.059, p = 0.001) were associated with HAMD scores. The plasma p‐tau181 levels (B = 1.328, SE = 0.576, p = 0.025) were associated with HAMA scores. Conclusion: Plasma biomarkers have significant potential in predicting anxiety and depressive symptoms in individuals with brain Aβ deposition. This can aid the early clinical diagnosis and intervention of AD. [ABSTRACT FROM AUTHOR]
Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 189332826
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mood Symptoms are Associated With Cognitive Status, Brain Amyloid‐Beta Deposition, and Plasma Biomarkers.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Wang%2C+Jingru%22&quot;&gt;Wang, Jingru&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Huang%2C+Lin%22&quot;&gt;Huang, Lin&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sun%2C+Linfang%22&quot;&gt;Sun, Linfang&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Guo%2C+Qihao%22&quot;&gt;Guo, Qihao&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22He%2C+Yingzi%22&quot;&gt;He, Yingzi&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Jing%2C+Yanping%22&quot;&gt;Jing, Yanping&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ilardi%2C+Ciro+Rosario%22&quot;&gt;Ilardi, Ciro Rosario&lt;/searchLink&gt; (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Depression+%26+Anxiety+%281091-4269%29%22&quot;&gt;Depression &amp; Anxiety (1091-4269)&lt;/searchLink&gt;. 11/14/2025, Vol. 2025, p1-9. 9p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Alzheimer&#39;s+disease%22&quot;&gt;Alzheimer&#39;s disease&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Biomarkers%22&quot;&gt;Biomarkers&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Anxiety%22&quot;&gt;Anxiety&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Amyloid+plaque%22&quot;&gt;Amyloid plaque&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Mental+depression%22&quot;&gt;Mental depression&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Blood+serum+analysis%22&quot;&gt;Blood serum analysis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Affective+disorders%22&quot;&gt;Affective disorders&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Cognitive+ability%22&quot;&gt;Cognitive ability&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Previous studies have indicated an association between mood symptoms and cognitive decline in the Alzheimer&#39;s disease (AD) spectrum. Amyloid‐beta (Aβ) deposition in the brain, which is a core pathological characteristic of AD, along with the presence of plasma biomarkers, such as phosphorylated tau protein (p‐tau), constitutes an early predictive indicator for AD. We attempted to explore the relationship between mood symptoms and the presence of AD‐related plasma biomarkers in patients with brain Aβ deposition. Method: We included 2612 participants aged ≥50 years (707 males; average age 66.98 &#177; 7.75 years) in this study. We used the Hamilton depression rating scale (HAMD) and Hamilton anxiety rating scale (HAMA) to assess mood symptoms. Cognitive status was categorized into AD, mild cognitive impairment (MCI), subjective cognitive decline (SCD), and normal cognition (NC). We used analysis of covariance (ANCOVA) to compare mood symptoms assessment scores in different cognitive groups after making adjustments for age, gender, and education. Linear regression analysis was used to investigate the association between mood scores and plasma biomarker levels, adjusting for positivity in Aβ PET imaging. Results: Compared to NC patients, patients with AD exhibited higher levels of depression (mean of 4.72 versus 3.39, p &lt; 0.05), whereas patients with SCD exhibited higher levels of anxiety (mean of 6.28 versus 4.26, p &lt; 0.05). After accounting for brain Aβ deposition and presence of plasma biomarkers, the plasma neurofilament light chain (NFL) levels (B = 0.211, SE = 0.059, p = 0.001) were associated with HAMD scores. The plasma p‐tau181 levels (B = 1.328, SE = 0.576, p = 0.025) were associated with HAMA scores. Conclusion: Plasma biomarkers have significant potential in predicting anxiety and depressive symptoms in individuals with brain Aβ deposition. This can aid the early clinical diagnosis and intervention of AD. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Depression &amp; Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=189332826
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1155/da/7515712
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1
    Subjects:
      – SubjectFull: Alzheimer's disease
        Type: general
      – SubjectFull: Biomarkers
        Type: general
      – SubjectFull: Anxiety
        Type: general
      – SubjectFull: Amyloid plaque
        Type: general
      – SubjectFull: Mental depression
        Type: general
      – SubjectFull: Blood serum analysis
        Type: general
      – SubjectFull: Affective disorders
        Type: general
      – SubjectFull: Cognitive ability
        Type: general
    Titles:
      – TitleFull: Mood Symptoms are Associated With Cognitive Status, Brain Amyloid‐Beta Deposition, and Plasma Biomarkers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, Jingru
      – PersonEntity:
          Name:
            NameFull: Huang, Lin
      – PersonEntity:
          Name:
            NameFull: Sun, Linfang
      – PersonEntity:
          Name:
            NameFull: Guo, Qihao
      – PersonEntity:
          Name:
            NameFull: He, Yingzi
      – PersonEntity:
          Name:
            NameFull: Jing, Yanping
      – PersonEntity:
          Name:
            NameFull: Ilardi, Ciro Rosario
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 11/14/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 10914269
          Numbering:
            – Type: volume
              Value: 2025
          Titles:
            – TitleFull: Depression & Anxiety (1091-4269)
              Type: main
ResultId 1